2014
DOI: 10.1007/s00280-014-2534-5
|View full text |Cite|
|
Sign up to set email alerts
|

RETRACTED ARTICLE: Aplysin enhances temozolomide sensitivity in glioma cells by increasing miR-181 level

Abstract: We found that aplysin can enhance the effect of TMZ on glioma cells by increasing miR-181 expression.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
18
0

Year Published

2014
2014
2020
2020

Publication Types

Select...
7
1
1

Relationship

1
8

Authors

Journals

citations
Cited by 21 publications
(18 citation statements)
references
References 11 publications
0
18
0
Order By: Relevance
“…Since miR-181b-abundant glioma cells is more sensitive to temozolomide (TMZ) [21], aplysin enhances TMZ action through increasing the expression of miR-181 in TMZ-resistant glioma cells, which results in MEK1 (mitogen-activated protein kinase kinase 1) downregulation [22]. …”
Section: Natural Compounds Affecting Mirnasmentioning
confidence: 99%
See 1 more Smart Citation
“…Since miR-181b-abundant glioma cells is more sensitive to temozolomide (TMZ) [21], aplysin enhances TMZ action through increasing the expression of miR-181 in TMZ-resistant glioma cells, which results in MEK1 (mitogen-activated protein kinase kinase 1) downregulation [22]. …”
Section: Natural Compounds Affecting Mirnasmentioning
confidence: 99%
“…(1) Bioactivities of some miRNAs are similar with the pharmacological effects of a given natural compounds on cancer cells [5, 7, 8, 16,19, 21, 22, 2427, 29, 30, 31], this similarity encourages researchers to wonder whether natural compound exhibits its effect by affecting these miRNAs. For example, miR-181 is related to TMZ-resistance of glioma, and interestingly, aplysin can also enhance the sensitivity of glioma cells to TMZ.…”
Section: Identification Of Natural Compound-related Mirnasmentioning
confidence: 99%
“…In addition, Gong et al . [ 137 ] demonstrated that aplysin ( 109 ) can enhance the effect of temozolomide (a chemotherapy drug) on glioma cells by increasing miR-181 expression. According to this, a recent study showed that aplysin ( 109 ) can actually induce apoptosis in glioma cells by interference with the HSP90/AKT pathway [ 138 ].…”
Section: Terpenoidsmentioning
confidence: 99%
“…Present study demonstrated that aplysin was believed to enhance the effect of temozolomide on glioma cells by increasing miR181 expression. [ 44 ] At the molecular level, expression of cyclin B1 (a positive cell cycle regulator) could be negatively regulated by miR181, which inhibited glioma cell proliferation. [ 45 ] Furthermore, miR-181c could enhance the effect of miR-21 as an anticancer target against glioma.…”
Section: Icro Rna S and G mentioning
confidence: 99%